As of March 1, 2024, an article processing charge (APC) of USD 400 + 20% VAT will be requested for newly submitted research, review, meta-analysis articles to the Anatolian Journal of Cardiology if they are accepted for publication.
The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis [Anatol J Cardiol]
The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis
Xiangwen Liang, Wenchao Xie, Zhihai Lin, Ming LiuDepartment of Cardiology, the First People’s Hospital of Yulin, the Sixth Affiliated Hospital of Guangxi Medical University; Guangxi-China Keywords: edoxaban, warfarin, atrial fibrillation, meta-analysis
Xiangwen Liang, Wenchao Xie, Zhihai Lin, Ming Liu. The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis. Anatol J Cardiol. 2021; 25(2): 77-88
Corresponding Author: Ming Liu, China Manuscript Language: English